Brain Scientific Inc. (BRSF)
- Previous Close
0.7500 - Open
0.7500 - Bid --
- Ask --
- Day's Range
0.7500 - 0.7500 - 52 Week Range
0.7500 - 1.8800 - Volume
5 - Avg. Volume
0 - Market Cap (intraday)
931,987 - Beta (5Y Monthly) -0.23
- PE Ratio (TTM)
-- - EPS (TTM)
-12.9900 - Earnings Date Apr 30, 2024 - May 4, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Brain Scientific Inc., a medtech company, provides neurology and motion products in the United States and internationally. It offers NeuroCap, a disposable soft layered cap with an integrated electrode circuit that is designed to address existing problems of conventional electroencephalography (EEG) systems; NeuroEEG amplifier and desktop software used to store and analyze data captured from the NeuroCap; and piezoelectric motors. The company is also developing NeuroHub, which allow users to access patient and clinical data to evaluate patient conditions remotely. Its NeuroCap and NeuroEEG products can be used for recording EEG in neurology clinics, urban and rural ED's, ICU's, urgent care clinics, nursing homes and assisted living facilities, sports facilities, remote clinical research studies, and other settings. Brain Scientific Inc. was founded in 2013 and is headquartered in Sarasota, Florida.
www.brainscientific.comRelated News
Performance Overview: BRSF
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BRSF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BRSF
Valuation Measures
Market Cap
931.99k
Enterprise Value
3.05M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.32
Price/Book (mrq)
0.22
Enterprise Value/Revenue
14.20
Enterprise Value/EBITDA
-0.39
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-47.81%
Return on Equity (ttm)
-681.55%
Revenue (ttm)
214.56k
Net Income Avi to Common (ttm)
-12.34M
Diluted EPS (ttm)
-12.9900
Balance Sheet and Cash Flow
Total Cash (mrq)
747.71k
Total Debt/Equity (mrq)
66.33%
Levered Free Cash Flow (ttm)
-208.39k